Literature DB >> 31865393

Comment on: Comorbidity burden in axial spondyloarthritis: a cluster analysis: reply.

Sizheng Steven Zhao1,2,3, Daniel H Solomon3,4, Nicola J Goodson1,2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31865393     DOI： 10.1093/rheumatology/kez573

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

1.  Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT).

Authors:  Casper Webers; Carmen Stolwijk; Olga Schiepers; Thea Schoonbrood; Astrid van Tubergen; Robert Landewé; Désirée van der Heijde; Annelies Boonen
Journal:  Arthritis Res Ther       Date:  2020-09-29       Impact factor: 5.156

2.  Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis.

Authors:  Sizheng Steven Zhao; Selina Robertson; Tzvi Reich; Nicolas L Harrison; Robert J Moots; Nicola J Goodson
Journal:  Rheumatology (Oxford)       Date:  2020-10-01       Impact factor: 7.580

3.  Depression and anxiety symptoms at TNF inhibitor initiation are associated with impaired treatment response in axial spondyloarthritis.

Authors:  Sizheng Steven Zhao; Gareth T Jones; David M Hughes; Robert J Moots; Nicola J Goodson
Journal:  Rheumatology (Oxford)       Date:  2021-12-01       Impact factor: 7.580
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.